ArticleEuropean journal of nuclear medicine and molecular imaging2020
Article in European journal of nuclear medicine and molecular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- [European journal of nuclear medicine and molecular imaging · 2025Pooled it
- Diagnostic test accuracies of F-18 FDG PET for characterisation of cardiac masses compared to conventional imaging techniques: systematic review and meta-analysis.The British journal of radiology · 2022Pooled it
- Cardiac metastasis from a Pancoast tumour presenting with ST-segment elevation and 2:1 atrioventricular block: a case report.European heart journal. Case reports · 2026Article
- Incidental detection of left ventricular metastasis from lung squamous cell carcinoma on FDG PET/CT: A rare case report.Asia Oceania journal of nuclear medicine & biology · 2026Article
- Advancing cardiac tumor diagnosis: evaluatingAmerican journal of cardiovascular disease · 2026Review
- Advances in the Molecular Imaging of Sarcoma: An Emphasis on Metabolic Imaging.Molecular imaging and biology · 2025Review
- Article
- A Comprehensive Review of Cardiac Tumors: Imaging, Pathology, Treatment, and Challenges in the Third Millennium.Diagnostics (Basel, Switzerland) · 2025Review
- Deep Learning-Powered CT-Less Multitracer Organ Segmentation From PET Images: A Solution for Unreliable CT Segmentation in PET/CT Imaging.Clinical nuclear medicine · 2025Article
- Hybrid cardiovascular imaging. A clinical consensus statement of the european association of nuclear medicine (EANM) and the european association of cardiovascular imaging (EACVI) of the ESC.European journal of nuclear medicine and molecular imaging · 2025Review
- Melanin-targeted [European journal of nuclear medicine and molecular imaging · 2023Observational
- Clinical characteristics of primary atrial tumor and their diagnostic value: A retrospective study of 10 years.Frontiers in surgery · 2023Article
- Accuracy of Cardiac Magnetic Resonance Imaging in Diagnosing Pediatric Cardiac Masses: A Multicenter Study.JACC. Cardiovascular imaging · 2022Article
- Multimodality imaging to distinguish between benign and malignant cardiac masses.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022Article
- Role ofJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022Article
- Diagnosis and staging of cardiac masses: additional value of CMR withEuropean journal of nuclear medicine and molecular imaging · 2022Article
- Cardiac Metastasis from Medullary Thyroid Cancers with Long-Term Survival under Vandetanib.European thyroid journal · 2021Article
- Letter to the Editor: It is time for the nuclear medicine community to define a unit for the total lesion glycolysis (TLG) and similar metrics.European journal of nuclear medicine and molecular imaging · 2021Article
- Incremental Value of FDG-PET in the Evaluation of Cardiac Masses.Current cardiology reports · 2021Review
- The diagnosis of a giant cardiac malignant lymphoma in the right ventricle: a case report.ESC heart failure · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeCorrect diagnosis and prognostic assessment of cardiac masses are crucial before therapy. We evaluated the diagnostic and prognostic value of
methods
resultsStatistically significant differences in various morphological features and metabolic indices between benign and malignant masses were found. An SUV
conclusion
Indexed as
Identifiers
31807883What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.